Cite
Wu D, Chen X, Xu Y, et al. Prognostic value of MLH1 promoter methylation in male patients with esophageal squamous cell carcinoma. Oncol Lett. 2017;13(4):2745-2750doi: 10.3892/ol.2017.5759.
Wu, D., Chen, X., Xu, Y., Wang, H., Yu, G., Jiang, L., Hong, Q., & Duan, S. (2017). Prognostic value of MLH1 promoter methylation in male patients with esophageal squamous cell carcinoma. Oncology letters, 13(4), 2745-2750. https://doi.org/10.3892/ol.2017.5759
Wu, Dongping, et al. "Prognostic value of MLH1 promoter methylation in male patients with esophageal squamous cell carcinoma." Oncology letters vol. 13,4 (2017): 2745-2750. doi: https://doi.org/10.3892/ol.2017.5759
Wu D, Chen X, Xu Y, Wang H, Yu G, Jiang L, Hong Q, Duan S. Prognostic value of MLH1 promoter methylation in male patients with esophageal squamous cell carcinoma. Oncol Lett. 2017 Apr;13(4):2745-2750. doi: 10.3892/ol.2017.5759. Epub 2017 Feb 22. PMID: 28454461; PMCID: PMC5403441.
Copy
Download .nbib